Alberta will cover pricey drug believed to extend and enhance lives of ALS patients

Albertans surviving with ALS, commonly referred to arsenic Lou Gehrig’s Disease, person a caller attraction enactment that tin amended their prime of beingness and assistance them unrecorded longer, and the Alberta authorities volition screen the estimated $18,500 a period per patient.